US 10813909
Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer
granted A61KA61K31/155A61K31/337
Quick answer
US patent 10813909 (Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer) held by The Regents of the University of California expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/155, A61K31/337, A61K31/351, A61K31/366